LifeStance Health (LFST) Cost of Revenue (2020 - 2024)

LifeStance Health (LFST) has 5 years of Cost of Revenue data on file, last reported at $212.3 million in Q3 2024.

• Cost of Revenue for Q3 2024 came in at $212.3 million, up 13.72% year-over-year; the trailing twelve-month figure through Sep 2024 was $829.8 million (up 14.78% YoY), and the FY2023 annual result was $753.6 million, up 21.05% from the prior year.
• Cost of Revenue declined to $212.3 million in Q3 2024 per LFST's latest filing, from $214.5 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $214.5 million in Q2 2024 and troughed at $31.3 million in Q2 2020.
• A 5-year average of $151.5 million and a median of $157.3 million in 2022 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2021 and 2024: Cost of Revenue surged 249.61% in 2021, then climbed 12.42% in 2024.
• A 5-year view of Cost of Revenue shows it stood at $68.8 million in 2020, then jumped by 97.17% to $135.7 million in 2021, then advanced by 22.78% to $166.7 million in 2022, then climbed by 18.37% to $197.3 million in 2023, then rose by 7.6% to $212.3 million in 2024.
• Business Quant data shows LFST's Cost of Revenue at $212.3 million in Q3 2024, $214.5 million in Q2 2024, and $205.7 million in Q1 2024.